Wuhan Bingbing Pharmaceutical Co., Ltd. has recalled 133,360 units of various pain relief patches, including LidoPatch (lidocaine HCl 3.6%), LidoPro (lidocaine 4%), Mencaine (lidocaine 4.5%), and Maximum Strength Lidocaine Cold & Hot Patches (lidocaine 4%). The recall was initiated because the manufacturer lost crucial manufacturing records and product samples, meaning they cannot guarantee the patches will remain safe or effective through their expiration dates. These products were distributed nationwide in the United States by various distributors including CVS Pharmacy, JAR Laboratories, and Terrain Pharmaceuticals.
The loss of manufacturing and quality control records means there is no assurance that the active ingredients (lidocaine and menthol) remain at the correct concentration or that the product is stable. Using a drug that does not meet specifications could result in ineffective pain relief or unexpected skin reactions.
Drug product return
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.